Craft

Illumina

Stock Price

$119

2024-05-06

Market Capitalization

$19 B

2024-05-06

Revenue

$4.5 B

FY, 2023

Illumina Summary

Company Summary

Overview
Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis. Its products include microarray scanners, reagents, barcoded tubes, hybridization chambers, in-vitro diagnostic instruments, etc. The company caters to education, government, hospitals, pharmaceutical, commercial, and other industries.
Type
Public
Status
Active
Founded
1998
HQ
San Diego, CA, US | view all locations
Website
https://www.illumina.com
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Steve Barnard

    Steve Barnard, Chief Technology Officer

  • Nicole Berry

    Nicole Berry, Head of Region, Americas

  • Kevin Pegels

    Kevin Pegels, Chief of Global Operations

  • Joydeep Goswami

    Joydeep Goswami, Chief Financial Officer, Chief Strategy and Corporate Development Officer

Operating MetricsView all

Patents (US)

1.2K
29.0%

FY, 2022

Patent Applications (US)

971
49.4%

FY, 2022

Facilities Leased, sq. ft.

3
100.0%

FY, 2022

LocationsView all

18 locations detected

  • San Diego, CA HQ

    United States

    5200 Illumina Way

  • Baltimore, MD

    United States

    801 w . baltimore st, suite 500

  • Foster City, CA

    United States

    200 Lincoln Centre Drive

  • Madison, WI

    United States

    524 Genomic Drive

  • San Diego, CA

    United States

    4795 Executive Dr

  • Melbourne, VIC

    Australia

    Level 3/535 Elizabeth St

and 12 others

Illumina Financials

Summary Financials

Revenue (Q1, 2024)
$1.1B
Gross profit (Q1, 2024)
$667.0M
Net income (Q1, 2024)
($126.0M)
Cash (Q1, 2024)
$1.1B
EBIT (Q1, 2024)
($111.0M)
Enterprise value
$18.4B

Footer menu